Immediate Impact

1 from Science/Nature 59 standout
Sub-graph 1 of 25

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease
2023 Standout
2 intermediate papers

Works of Hiroshi Kaneda being referenced

Prognostic factors and optimal therapy for stages I–II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study
2017
ICOS costimulates invariant NKT cell activation
2004

Author Peers

Author Last Decade Papers Cites
Hiroshi Kaneda 36 65 34 113 95 33 366
Osman İnan 40 79 79 94 65 32 407
Alireza Nazari 13 18 34 86 66 30 344
Emel Ebru Pala 19 61 68 58 46 42 323
Laura Botticelli 17 70 94 41 48 35 375
J Koudstaal 10 27 40 56 68 26 367
Kwang Sun Suh 37 95 82 55 60 27 333
Christine Bekos 4 23 77 108 106 35 401
Rong Liang 3 29 18 87 102 37 409
Amira Elbendary 5 15 33 85 93 35 369
Anitha Thomas 10 42 81 81 59 53 316

All Works

Loading papers...

Rankless by CCL
2026